Skip to main content
Log in

Successful treatment of congenital chylous ascites with a somatostatin analogue

  • Case Report
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

Abstract

Congenital chylous ascites (CCA) results from maldevelopment of the intra-abdominal lymphatic system. Newborns present with respiratory distress and abdominal distention. Medical treatment of CCA is often prolonged. A newborn with CCA was treated with octreotide, a somatostatin analogue, resulting in rapid and complete resolution of the ascites.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ahren B, Walther B (1989) Reduction of secretion from a small bowel fistula by somatostatin. Acta Chir Scand 155: 205–208

    PubMed  CAS  Google Scholar 

  2. Alliet P, Young C, Lebenthal E (1992) Chylous ascites: total parenteral nutrition as primary therapeutic modality. Eur J Pediatr 70: 213–214

    Article  Google Scholar 

  3. Cochran WJ, Klish WJ, Brown MR, Lyons JM, Curtis T (1985) Chylous ascites in infants and children: a case report and literature review. J Pediatr Gastroentrol Nutr 4: 668–673

    Article  CAS  Google Scholar 

  4. Craven CE, Goldman AS, Larson DL, Patterson M, Hendrick CK (1987) Congenital chylous ascites: lymphangiographic demonstration of obstruction of the cisterna chyli and chylous reflux into the peritoneal space and small intestine. J Pediatr 70: 340–345

    Google Scholar 

  5. Hussaini SH, Pereira SP, Murphy GM, Kennedy C, Woss JA, Besser GM, Dowling RH (1995) Composition of gallbladder stones associated with octreotide: response to oral ursodeoxycholic acid. Gut 36: 126–132

    Article  PubMed  CAS  Google Scholar 

  6. Kocak S, Bumin C, Karayalacin K, Alacryir I, Aribal D (1994) Treatment of external biliary, pancreatic and intestinal fistulas with a somatostatin analog. Dig Dis 12: 62–68

    Article  PubMed  CAS  Google Scholar 

  7. Kuret JA, Murad F (1990) Adenohypophyseal hormones and related substances. In: Goodman AG, Rall TW, Nies AS, Taylor P (eds) The pharmacologic basis of therapeutics. Pergamon, New York, pp 1355–1356

    Google Scholar 

  8. Pawlik WW, Gustaw P, Gzarnobilski K, Sendur R, Konturek SJ (1989) Effects of somatostatin on intestinal circulation and oxygen consumption. Acta Physiol Hung 74: 277–283

    PubMed  CAS  Google Scholar 

  9. Smeitzer DM, Stickler GB, Fleming RE (1985) Primary lymphatic dysplasia in children: chylothorax, chylous ascites and generalized lymphatic dysplasia. Eur J Pediatr 145: 286–292

    Article  Google Scholar 

  10. Wales JK (1994) Octreotide treatment associated with adrenal suppression and poor feedings. Arch Dis Child 70: 553–555

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caty, M.G., Hilfiker, M.L., Azizkhan, R.G. et al. Successful treatment of congenital chylous ascites with a somatostatin analogue. Pediatr Surg Int 11, 396–397 (1996). https://doi.org/10.1007/BF00497824

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00497824

Key words

Navigation